120 related articles for article (PubMed ID: 6771092)
21. Chorionic gonadotropin in women fitted with intrauterine device.
Yarkoni S; Zer TA; Schenker JG
Infertility; 1980; 3(1):23-7. PubMed ID: 12263338
[TBL] [Abstract][Full Text] [Related]
22. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
24. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
[TBL] [Abstract][Full Text] [Related]
25. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
Niaraki MA; Moghissi KS; Borin K
Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
[TBL] [Abstract][Full Text] [Related]
26. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
Newton J; Szontagh F; Lebech P; Rowe P
Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
[TBL] [Abstract][Full Text] [Related]
27. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
Laumas V; Jain AK; Jha P; Rahman SA; Kumar D; Malik BK; Sarkar NN; Takkar D; Hingorani V; Laumas KR
Contraception; 1981 Feb; 23(2):211-25. PubMed ID: 6786828
[TBL] [Abstract][Full Text] [Related]
28. [Sensitivity of pituitary gonadotropins to luliberin in women using intrauterine contraceptive devices].
Kononova ES; Beskrovnyĭ SV; Svechnikova FA
Akush Ginekol (Mosk); 1984 Aug; (8):60. PubMed ID: 6435469
[TBL] [Abstract][Full Text] [Related]
29. Human chorionic gonadotropin in intrauterine device users.
Shalit A; Jaschevatzky OE; Kampf D; Leiserowitz DM; Grünstein S
Int J Fertil; 1980; 25(2):134-6. PubMed ID: 6117529
[TBL] [Abstract][Full Text] [Related]
30. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
31. Serum gonadotropin and steroid patterns in early human gestation.
Mishell DR; Thorneycroft IH; Nagata Y; Murata T; Nakamura RM
Am J Obstet Gynecol; 1973 Nov; 117(5):631-42. PubMed ID: 4742372
[TBL] [Abstract][Full Text] [Related]
32. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
33. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
Balogh A; Ditrói F; Lampé LG
Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
[TBL] [Abstract][Full Text] [Related]
34. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women.
Jeppsson S; Rannevik G; Thorell JI; Wide L
Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431
[TBL] [Abstract][Full Text] [Related]
35. The menstrual cycle in women using an intrauterine device.
Faundes A; Segal SJ; Adejuwon CA; Brache V; Leon P; Alvarez-Sanchez F
Fertil Steril; 1980 Nov; 34(5):427-30. PubMed ID: 7439408
[TBL] [Abstract][Full Text] [Related]
36. Ovulation inhibition by daily i.m. administration of a highly active LH-RH analog (d-ser(TBU)6-LH-RH-(1-9)-nonapeptide-ethylamide).
Baumann R; Kuhl H; Taubert HD; Sandow J
Contraception; 1980 Feb; 21(2):191-7. PubMed ID: 6768492
[TBL] [Abstract][Full Text] [Related]
37. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
[TBL] [Abstract][Full Text] [Related]
38. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
40. Monitoring of ovulation induction.
Wu CH
Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
